Professor Hiroyuki Moriuchi

Speciality / Research theme / Keywords

Pediatrics

Supervision

Masters Programme

Background

• 1984 M. D., summa cum laude, Nagasaki University School of Medicine
• 1988-90 Research Fellow in Virus Laboratory, Sendai National Hospital, Japan
• 1990-99 Visiting Fellow, Visiting Associate, and Staff Scientist in the NIAID, NIH, USA
• 1994-99 Clinical Staff in the Clinical Center, NIH, USA
• 1996 Young Investigator Award (American Society for Microbiology)
• 1999- Professor and Head, Department of Pediatrics, Nagasaki University School of Medicine
• 2002- Professor, Nagasaki University Graduate School of Biomedical Sciences
• 2010 Principal Investigator, Standardization of Health Guidance for Prevention of Mother-to-Child Transmission of Human T-cell Leukemia Virus type I (sponsored by Ministry of Health, Labour and Welfare)
• 2011- Committee on Prevention of Human T-cell Leukemia Virus type I Infection (MHLW, Japan)
• 2012- Advisor, Association for Congenital Toxoplasma and Cytomegalovirus Infections

Five MOST IMPORTANT/INTERESTING recent publications

1. Ngwe Tun MM, Luvai EAC, Toizumi M, Moriuchi M, Takamatsu Y, Inoue S, Urano T, Bui MX, Thai Hung D, Thi Nguyen HA, Anh DD, Yoshida LM, Moriuchi H, Morita K. Possible vertical transmission of Chikungunya virus infection detected in the cord blood samples from a birth cohort in Vietnam. Journal of Infection and Public Health. 2024; 17(6):1050-1056.
2. Toizumi M, Vu CN, Huynh HT, Uematsu M, Tran VT, Vo HM, Nguyen HAT, Ngwe Tun MM, Bui MX, Dang DA, Moriuchi H, Yoshida LM. A Birth Cohort Follow-Up Study on Congenital Zika Virus Infection in Vietnam. Viruses. 2023; 15(9):1928.
3. Kawata S, Morimoto S, Kosai K, Kawamoto Y, Nakashima Y, Morinaga Y, Yanagihara K, Yoshida LM, Moriuchi H. The fecal carriage rate of extended-spectrum β-lactamase-producing or carbapenem-resistant Enterobacterales among Japanese infants in the community at the 4-month health examination in a rural city. Frontiers in Cellular and Infection Microbiology. 2023; 13:1168451. 
4. Morioka I, Kakei Y, Omori T, Nozu K, Fujioka K, Takahashi N, Yoshikawa T, Moriuchi H, Ito Y, Oka A, Japanese Congenital Cytomegalovirus Study Group. Oral Valganciclovir Therapy in Infants Aged ≤2 Months with Congenital Cytomegalovirus Disease: A Multicenter, Single-Arm, Open-Label Clinical Trial in Japan. Journal of Clinical Medicine. 2022; 11(13):3582.
5. Toizumi M, Tanaka S, Moriuchi M, Nguyen HT, Takegata M, Iwasaki C, Kitamura N, Do HT, Dang DA, Yoshida LM, Moriuchi H. Rubella seroprevalence among mothers and incidence of congenital rubella three years after rubella vaccine introduction in Vietnam. Human Vaccines & Immunotherapeutics. 2021; 17(9):3156-3161. 

Message

Children account for the majority of victims of infectious diseases. Until recently, approximately 10 million children under age five had passed away every year, and two thirds of them died from infectious diseases. More than two million of them could have been saved by vaccination. Besides, many children acquire devastating pathogens from their mothers, despite the fact that appropriate management of pregnant women should be able to reduce such victims. As a pediatrician, I would like to appeal to you concerning what we should do to prevent such tragedies.